General Information of Drug (ID: DM0762O)

Drug Name
Fenfluramine Drug Info
Synonyms
Acino; Adifax; Adipomin; Fenfluramina; Fenfluraminum; Isomeride; Obedrex; Pesos; Ponderex; Rotondin; Dexfenfluramina [Spanish]; Dexfenfluraminum [Latin]; Fenfluramina [DCIT]; Fenfluramine hydrochloride; Levofenfluramine [INN]; Ponderax PA; S 768; D-Fenfluramine; Dexfenfluramine [INN:BAN]; Fenfluramine (INN); Fenfluramine [INN:BAN]; Fenfluraminum [INN-Latin]; Ponderax (TN); Fenfluramine, (+-)-Isomer; N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine; D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine; N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine; N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine; N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-(9CI); Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-(9CI);Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-(9CI); (+)-Fenfluramine; (+-)-Fenfluramine; (+/-)-Fenfluramine hydrochloride; (S)-Fenfluramine; 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane; 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane; 2-Ethylamino-1-(3-trifluoromethylphenyl)propane; 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine
Indication
Disease Entry ICD 11 Status REF
Dravet syndrome 8A61.11 Phase 3 [1]
LennoxGastaut syndrome 8A62.1 Phase 3 [1]
Obesity 5B81 Withdrawn from market [2]
Cross-matching ID
PubChem CID
3337
ChEBI ID
CHEMBL5000
CAS Number
CAS 458-24-2
TTD Drug ID
DM0762O
VARIDT Drug ID
DR00583

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Patented Agent(s)
Drug(s) Targeting 5-HT receptor (5HTR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metergolin DMJFP6G Hyperprolactinaemia 5A60.1 Approved [7]
Paliperidone DM7NPJS Psychotic disorder 6A20-6A25 Approved [8]
Ramosetron DMH7GN8 Diarrhea-predominant irritable bowel syndrome DD91.01 Approved [7]
Pizotyline DMV74ZH Headache 8A80-8A84 Approved [8]
Tandospirone DMPHWU6 Anxiety disorder 6B00-6B0Z Approved [7]
Nafronyl DMVMQ1L Cerebrovascular ischaemia 8B1Z Approved [8]
ITI-007 DMUQ1DO Depression 6A70-6A7Z Phase 3 [9]
MIN-117 DMSLIW6 Major depressive disorder 6A70.3 Phase 2 [9]
Lu-AA34893 DM2ZUXK Anxiety disorder 6B00-6B0Z Phase 2 [10]
SEP--4199 DMA12HB Bipolar disorder 6A60 Phase 2 [11]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [13]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [14]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [15]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [16]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [17]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [18]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [19]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [21]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein cordon-bleu (COBL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [22]
Testosterone DM7HUNW Hot flushes GA30 Approved [23]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [24]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [25]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [15]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [26]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [27]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [28]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [16]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [29]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [30]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [31]
Fluphenazine DMIT8LX Psychotic disorder 6A20-6A25 Approved [32]
Paliperidone DM7NPJS Psychotic disorder 6A20-6A25 Approved [33]
Haloperidol DM96SE0 Delirium Approved [33]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [35]
Olanzapine DMPFN6Y Bipolar depression Approved [36]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [37]
Arsenic DMTL2Y1 N. A. N. A. Approved [38]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [39]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [40]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [40]
Fluoxetine DM3PD2C Bipolar depression Approved [40]
Fluphenazine DMIT8LX Psychotic disorder 6A20-6A25 Approved [32]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [41]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [42]
Testosterone DM7HUNW Hot flushes GA30 Approved [43]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [44]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [24]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [25]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By DNA ligase 4 (LIG4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [45]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [46]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [48]
Bortezomib DMNO38U Leukemia Approved [49]
Arsenic DMTL2Y1 N. A. N. A. Approved [50]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [16]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [51]
Urethane DM7NSI0 N. A. N. A. Phase 4 [52]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [53]
Testosterone DM7HUNW Hot flushes GA30 Approved [23]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [54]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [55]
Arsenic DMTL2Y1 N. A. N. A. Approved [56]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [57]
MK-2206 DMT1OZ6 Rectal adenocarcinoma 2B92 Phase 2 [58]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [59]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [60]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Acid ceramidase (ASAH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [61]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [53]
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [61]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [64]
Fluoxetine DM3PD2C Bipolar depression Approved [61]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [41]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Mucin-like protein 3 (MUCL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [65]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [66]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [57]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [38]
Napabucasin DMDZ6Q3 Colorectal cancer 2B91.Z Phase 3 [67]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [68]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [66]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [69]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [70]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [70]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [71]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [64]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [66]
Quercetin DM3NC4M Obesity 5B81 Approved [64]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [24]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [55]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [73]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [74]
Urethane DM7NSI0 N. A. N. A. Phase 4 [52]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [70]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [22]
Testosterone DM7HUNW Hot flushes GA30 Approved [43]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [43]
Leflunomide DMR8ONJ Arthritis FA20 Approved [75]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [54]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [25]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [76]
Ethanol DMDRQZU Chronic pain MG30 Approved [77]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [55]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Olfactory receptor 2W3 (OR2W3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [78]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [79]
1,6-hexamethylene diisocyanate DMLB3RT Discovery agent N.A. Investigative [80]
Drug(s) Affected By Protein GAPT (GAPT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [81]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [29]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [82]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [66]
Methotrexate DM2TEOL Anterior urethra cancer Approved [83]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [84]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [25]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [85]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [73]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [86]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [83]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [17]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [22]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [87]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [88]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [89]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [90]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [26]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [28]
Urethane DM7NSI0 N. A. N. A. Phase 4 [52]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [28]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [91]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [22]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [92]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [15]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [16]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [70]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [93]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [66]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [88]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [94]
Testosterone DM7HUNW Hot flushes GA30 Approved [43]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [76]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [81]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [16]
Nitazoxanide DMOWLVG Clostridioides difficile infection 1A04 Approved [96]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [74]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myozenin-3 (MYOZ3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Folic Acid DMEMBJC Colorectal carcinoma Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [38]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [17]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [22]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [66]
Drug(s) Affected By Tumor protein D55 (TPD52L3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [98]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [78]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [64]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [89]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [24]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [99]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [15]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [52]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [22]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [101]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [102]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [89]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [88]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [93]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [47]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [25]
Arsenic DMTL2Y1 N. A. N. A. Approved [103]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [93]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [79]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [31]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [105]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [106]
Bortezomib DMNO38U Leukemia Approved [49]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [98]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [107]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [108]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [20]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
5-HT receptor (5HTR) TT85JO3 NOUNIPROTAC Antagonist [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
5-hydroxytryptamine receptor 2A (HTR2A) OTWXJX0M 5HT2A_HUMAN Protein Interaction/Cellular Processes [4]
5-hydroxytryptamine receptor 2B (HTR2B) OTM1AD9J 5HT2B_HUMAN Drug Response [5]
5-hydroxytryptamine receptor 2C (HTR2C) OT6H8DE0 5HT2C_HUMAN Protein Interaction/Cellular Processes [4]
Acid ceramidase (ASAH1) OT1DNGXL ASAH1_HUMAN Gene/Protein Processing [6]
Coiled-coil domain-containing protein 62 (CCDC62) OTTIAOBP CCD62_HUMAN Gene/Protein Processing [6]
Cytoplasmic dynein 2 heavy chain 1 (DYNC2H1) OTLC8K6B DYHC2_HUMAN Gene/Protein Processing [6]
Dedicator of cytokinesis protein 8 (DOCK8) OTNQLL21 DOCK8_HUMAN Gene/Protein Processing [6]
Dickkopf-like protein 1 (DKKL1) OTWS7DED DKKL1_HUMAN Gene/Protein Processing [6]
DNA ligase 4 (LIG4) OT40DNXU DNLI4_HUMAN Gene/Protein Processing [6]
Follistatin-related protein 5 (FSTL5) OT18C29S FSTL5_HUMAN Gene/Protein Processing [6]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4613).
3 Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
4 Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol. 2000 Jan;57(1):75-81.
5 Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension. Cardiovasc Res. 2003 Dec 1;60(3):518-28. doi: 10.1016/j.cardiores.2003.09.015.
6 Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells. Pulm Circ. 2011 Jul-Sep;1(3):405-18. doi: 10.4103/2045-8932.87310.
7 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
8 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
9 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
10 Encyclopedia of Psychopharmacology. Ian Stolerman. 2010. Page(105).
11 ClinicalTrials.gov (NCT03543410) A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression. U.S. National Institutes of Health.
12 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
13 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
14 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
15 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
16 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
17 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
18 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
19 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
22 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
23 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
24 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
25 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
26 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
27 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
28 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
29 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
30 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
31 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
32 Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11927-32. doi: 10.1073/pnas.0609752104. Epub 2007 Jul 2.
33 Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12.
34 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
35 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
36 No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation. Pharmacogenomics J. 2007 Aug;7(4):275-81. doi: 10.1038/sj.tpj.6500418. Epub 2006 Sep 19.
37 Nephrotoxicity induced by cisplatin is primarily due to the activation of the 5-hydroxytryptamine degradation system in proximal renal tubules. Chem Biol Interact. 2021 Nov 1;349:109662. doi: 10.1016/j.cbi.2021.109662. Epub 2021 Sep 21.
38 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
39 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
40 Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulatio... Mol Pharmacol. 2008 Mar;73(3):748-57.
41 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
42 Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. Clin Neuropharmacol. 1993;16 Suppl 3:S19-31.
43 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
44 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
45 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
46 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
47 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
48 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
49 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
50 Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123-31. doi: 10.1097/cej.0b013e328341017a.
51 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
52 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
53 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
54 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
55 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
56 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
57 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
58 Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBP axis and inducing M1 macrophage polarization. Cell Biol Toxicol. 2022 Aug;38(4):611-628. doi: 10.1007/s10565-021-09636-7. Epub 2021 Aug 16.
59 Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013 Dec 9;24(6):777-90. doi: 10.1016/j.ccr.2013.11.003.
60 Genome-wide transcriptional and functional analysis of human T lymphocytes treated with benzo[alpha]pyrene. Int J Mol Sci. 2018 Nov 17;19(11).
61 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
62 Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Toxicol Sci. 2007 Mar;96(1):101-14.
63 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
64 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
65 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
66 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
67 Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1839-44. doi: 10.1073/pnas.1424171112. Epub 2015 Jan 20.
68 MCM5 as a target of BET inhibitors in thyroid cancer cells. Endocr Relat Cancer. 2016 Apr;23(4):335-47. doi: 10.1530/ERC-15-0322. Epub 2016 Feb 24.
69 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
70 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
71 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
72 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
73 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
74 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
75 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
76 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
77 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
78 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
79 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
80 Gene profiles of THP-1 macrophages after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol In Vitro. 2009 Sep;23(6):1151-62. doi: 10.1016/j.tiv.2009.06.007. Epub 2009 Jun 13.
81 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
82 Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res. 2007 Jun 1;67(11):5425-33. doi: 10.1158/0008-5472.CAN-06-4431.
83 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
84 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
85 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
86 RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. Toxicol Appl Pharmacol. 2018 Oct 1;356:44-53.
87 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
88 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
89 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
90 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
91 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.
92 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
93 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
94 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
95 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
96 Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study. Environ Health Perspect. 2015 May;123(5):458-66. doi: 10.1289/ehp.1408775. Epub 2015 Jan 13.
97 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
98 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
99 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
100 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
101 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
102 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
103 Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014 Jun;139(2):328-37. doi: 10.1093/toxsci/kfu053. Epub 2014 Mar 27.
104 Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in?vivo assays in mice. Neuropharmacology. 2016 Nov;110(Pt A):143-153. doi: 10.1016/j.neuropharm.2016.07.016. Epub 2016 Jul 20.
105 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
106 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
107 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
108 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.